New Key Statistics Module, Z-Score and F-Score
AMEX:PTHS Key Ratios
| Market Cap $ M | 83.84 |
| Enterprise Value $ M | 132.76 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.68 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 43.00 |
| EPS (TTM) $ | -26.36 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -114.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -1.54 |
| EV-to-EBITDA | -1.63 |
| PEG | -- |
| Shares Outstanding M | 3.83 |
| Net Margin (%) | -199.50 |
| Operating Margin % | -133.42 |
| Pre-tax Margin (%) | -216.56 |
| Quick Ratio | 1.31 |
| Current Ratio | 1.98 |
| ROA % (ttm) | -79.94 |
| ROE % (ttm) | -347.68 |
| ROIC % (ttm) | -69.93 |
| Dividend Yield % | -- |
| Altman Z-Score | -2.28 |
PTHS Number of Guru Trades
PTHS Volume of Guru Trades
Gurus Latest Trades with AMEX:PTHS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:PTHS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pelthos Therapeutics Inc Insider Transactions
No Available Data
News about AMEX:PTHS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers